Patients with isolated locoregional breast cancer recurrences should be treated with curative intent. Mastectomy is regarded as the standard of care for patients with ipsilateral breast tumor recurrence. In a selected group of patients, partial breast irradiation after second breast-conserving surgery is a viable alternative to mastectomy. If a second breast conservation is performed, additional irradiation should be mandatory, especially in patients who had not been irradiated previously. In case of re-irradiation, the largest experience exists for multi-catheter brachytherapy. Prospective clinical trials are needed to clearly define selection criteria, long-term local control, and toxicity. In patients with resectable locoregional breast cancer recurrences after mastectomy, multi-modal therapy comprising complete resection, radiation therapy in previously unirradiated patients, and systemic therapy results in 5-year disease-free and overall survival rates of 69% and 88%, respectively. In radiation-naive patients with unresectable, isolated locoregional recurrences, radiation therapy is mandatory. In selected patients with previous irradiations and unresectable locoregional recurrences, a second irradiation as part of an individual treatment concept can be applied. The increased risk of severe toxicity should always be weighed up against the potential clinical benefit. A combination therapy with hyperthermia can further improve the treatment results.

Keywords:
Ipsilateral breast tumor recurrence, Local recurrence breast, Locoregional recurrence breast cancer, Hyperthermia, Radiation therapy, Brachytherapy, Chest wall recurrence, Breast cancer, Re-irradiation breast
1.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011;378:1707-1716.
2.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials Lancet 2014;383:2127-2135.
3.
Christiansen P, Al Suliman N, Bjerre K, Moller S: Recurrence pattern and prognosis in low-risk breast cancer patients - data from the DBCG 89-A programme. Acta Oncol 2008;47:691-703.
4.
Bartelink H, Maingon P, Poortmans P, et al.: Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 2015;16:47-56.
5.
Sedlmayer F, Sautter-Bihl ML, Budach W, et al.: DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 2013;189:825-833.
6.
Wahl AO, Rademaker A, Kiel K, et al.: Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys 2008;70:477-484.
7.
Danish Breast Cancer Cooperative Group, Nielsen HM, Overgaard M, Grau C, et al.: Study of failure pattern among high-risk breast cancer patients with or without post-mastectomy radiotherapy in addition to adjuvant systemic therapy: long term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006;24:2268-2275.
8.
Bedwinek J: Natural history and management of isolated local-regional recurrence following mastectomy. Semin Radiat Oncol 1994;4:260-269.
9.
van Tienhoven G, Voogd AC, Peterse JL, et al.: Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999,35:32-38.
10.
Fisher B, Anderson S, Bryant J, et al.: Twenty‐year follow‐up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241.
11.
Wapnir IL, Anderson SJ, Mamounas EP, et al.: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node‐positive adjuvant breast cancer trials. J Clin Oncol 2006;24:2028-2037.
12.
Bouganim M, Tsetkova E, Clemons M, et al.: Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research. Breast Cancer Res Treat 2013;139:603-606.
13.
Sedlmayer F, Sautter-Bihl ML, Budach W, et al.: DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Strahlenther Onkol 2013;189:825-833.
14.
Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Langversion 3.0, Aktualisierung 2012. www.leitlinienprogramm- onkologie.de.
15.
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Breast Cancer. www.nccn.org/professionals/physician_gls/pdf/breast.pdf [last accessed April 13, 2015].
16.
Wenz F, Sperk E, Budach W, et al.: DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol 2014;190:705-714.
17.
Anderson SJ, Wapnir I, Dignam JJ: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009;27:2466-2473.
18.
Fowble B, Solin LJ, Schultz DJ, et al.: Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990;19:833-842.
19.
Vila J, Garcia-Etienne CA, Vavassori A, Gentilini O: Conservative surgery for ipsilateral breast tumor recurrence. J Surg Oncol 2014;110:62-67.
20.
RTOG 1014: Radiation therapy in treating women with locally recurrent breast cancer previously treated with repeat breast-preserving surgery. https://clinicaltrials.gov/ct2/results?term=01082211.
21.
Sautter-Bihl ML, Sedlmayer F, Budach W, et al.: When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol 2012;188:1069-1073.
22.
Kirchheiner K, Czajka A, Ponocny-Seliger E, et al.: Validation and practical implementation of a multidisciplinary cancer distress screening questionnaire. Strahlenther Onkol 2013;189:573-578.
23.
Veronesi U, Marubini E, Del Vecchio M, et al.: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995;87:19-27.
24.
Gujral DM, Sumo G, Owen JR, et al.: Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole breast radiotherapy on the rate of new primaries. Int J Radiat Oncol Biol Phys 2011;79:19-25.
25.
Smith TE, Lee D, Turner BC, Carter D, Haffty BG: True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000;48:1281-1289.
26.
Komoike Y, Akiyama F, Iino Y, et al.: Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 2005;12:104-111.
27.
Huang E, Buchholz TA, Meric F, et al.: Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable out-comes than true local disease recurrences. Cancer 2002;95:2059-2067.
28.
Nishimura S, Takahashi K, Akiyama F, et al.: Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer 2005;12:112-117.
29.
Fodor J, Major T, Polgár C, et al.: Prognosis of patients with local recurrence after mastectomy or conservative surgery for early‐stage invasive breast cancer. Breast 2008;17:302-308.
30.
van Laar C, van der Sangen MJ, Poortmans PM, et al.: Local recurrence following breast‐conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population‐based cohort of 1143 patients. Eur J Cancer 2013;49:3093-3101.
31.
Miles RC, Gullerud RE, Lohse CM, et al.: Local recurrence after breast‐conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol 2012;19:1153-1159.
32.
Alpert TE, Kuerer HM, Arthur DW, et al.: Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 2005;63:845-851.
33.
Sedlmayer F, Zehentmayr F, Fastner G: Partial breast re-irradiation for local recurrence of breast carcinoma: benefit and long term side effects. Breast 2013;22(suppl 2):S141-S146.
34.
Hannoun-Levi JM, Resch A, Gal J, et al.: Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol 2013;108:226-231.
35.
Resch A, Fellner C, Mock U, et al.: Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy - a second chance to preserve the breast. Radiology 2002;225:713-718.
36.
Kauer-Dorner D, Pötter R, Resch A, et al.: Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol 2012;102:96-101.
37.
Chadha M, Feldman S, Boolbol S, et al.: The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. Brachytherapy 2008;7:22-28.
38.
Trombetta M, Julian T, Bhandari T, et al.: Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Brachytherapy 2008;7:29-36.
39.
Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL: The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 1991;21:299-310.
40.
http://www.rtog.org/clinicaltrials/protocoltable/studydetails.aspx?study=1014.
41.
Kraus-Tiefenbacher U, Bauer L, Scheda A, et al.: Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer 2007;7:178.
42.
Guix B, Lejárcegui JA, Tello JI, et al.: Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. Int J Radiat Oncol Biol Phys 2010;78:804-810.
43.
Hannoun-Levi JM, Castelli J, Plesu A, et al.: Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction. Brachytherapy 2011;10:171-177.
44.
Budach W, Matuschek C, Bölke E, et al.: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 2015;191:623-633.
45.
Sautter-Bihl ML, Sedlmayer F, Budach W, et al.: DEGRO practical guidelines: radiotherapy of breast cancer III - radiotherapy of the lymphatic pathways. Strahlenther Onkol 2014;190:342-351.
46.
Sautter-Bihl ML, Sedlmayer F, Budach W, et al.: How nescience may obscure evidence. Strahlenther Onkol 2014;190:861-863.
47.
Katz A, Strom EA, Buchholz TA, et al.: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000;18:2817-2827.
48.
Halverson K, Perez C, Kuske R, et al.: Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys 1990;19:851-858.
49.
Chagpar A, Kuerer HM, Hunt KK, Strom EA, Buchholz TA: Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys 2003;57:128-135.
50.
Skinner HD, Strom EA, Motwani SB, et al.: Radiation dose escalation for locoregional recurrence of breast cancer after mastectomy. Radiat Oncol 2013;8:13.
51.
Borner M, Bacchi M, Goldhirsch A, et al.: First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter trial comparing systemic treatment with observation after excision and radiation. J Clin Oncol 1994;12:2071-2077.
52.
Aebi S, Gelber S, Anderson SJ: Chemotherapy for isolated locoregional recurrence of breast cancer: the CALOR randomised trial. Lancet Oncol 2014;15:156-163.
53.
Laramore GE, Griffin TW, Parker RG, Gerdes AJ: The use of electron beams in treating local recurrence of breast cancer in previously irradiated fields. Cancer 1978;41:991-995.
54.
Elkort RJ, Kelly W, Mozden PJ, Feldman MI: A combined treatment program for the management of locally recurrent breast cancer following chest wall irradiation. Cancer 1980;46:647-653.
55.
Wahl AO, Rademaker A, Kiel KD, et al.: Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys 2008;70:477-484.
56.
Phromratanapongse P, Steeves RA, Severson SB, Paliwal BR: Hyperthermia and irradiation for locally recurrent previously irradiated breast cancer. Strahlenther Onkol 1991;167:93-97.
57.
Van der Zee J, van der Holt B, Rietveld PJM, et al.: Re-irradiation combined with hyperthermia in recurrent breast cancer is a worthwhile local palliation. Br J Cancer 1999;79:483-490.
58.
Amicheti M, Valdagni R, Graiff C, Valentini A: Local-regional recurrences of breast cancer: treatment with radiation therapy and local microwave hyperthermia. Am J Clin Oncol 1991;14:60-65.
59.
Kapp DS, Cox RC: Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 1995;33:887-899.
60.
Linthorst M, van Geel AN, Baaijens M, et al.: Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiother Oncol 2013;109:188-193.
61.
Linthorst M, van Geel AN, Baartman EA, et al.: Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wall. Strahlenther Onkol 2013;189:387-393.
62.
Karasawa K, Katsui K, Seki K, et al.: Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer. Breast Cancer 2003;10:268-274.
63.
Semrau S, Gerber B, Reimer T, Klautke G, Fietkau R: Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis. Strahlenther Onkol 2006;182:596-603.
64.
Zagar TM, Higgins KA, Miles EF, et al.: Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy. Radiother Oncol 2010;97:535-540.
65.
Harms W, Krempien R, Hensley FW, Berns C, Wannenmacher M, Fritz P: Results of chest wall re-irradiation using pulsed dose rate (PDR) brachytherapy moulds for breast cancer local recurrences. Int J Radiat Oncol Biol Phys 2001;49:205-210.
66.
Vernon CC, Hand JW, Field SB, et al.: Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials - International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996;35:731-744.
67.
Jones EL, Oleson JR, Prosnitz LR, et al.: Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005;23:3079-3085.
68.
Linthorst M, Baaijens M, Wiggenraad R, et al.: Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol 2015;May 19 [Epub ahead of print].
69.
Salvadori B, Marubini E, Miceli R, et al.: Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg 1999;86:84-87.
70.
Voogd AC, van Tienhoven G, Peterse HL, et al.: Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch study group on Local Recurrence after Breast Conservation (BORST). Cancer 1999;85:437-446.
71.
Ishitobi M, Komoike Y, Nakahara S, Motomura K, Koyama H, Inaji H: Repeat lumpectomy for ipsilateral breast tumor recurrence after breast-conserving treatment. Oncology 2011;81:5381-5366.
72.
Gentilini O, Botteri E, Veronesi P, et al.: Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol 2012;19:3771-3776.
73.
Deutsch M: Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 2002;53:687-691.
74.
Delanian S, Housset M, Brunel P, et al.: Iridium 192 plesiocurietherapy using silicone elastomer plates for extensive locally recurrent breast cancer following chest wall irradiation. Int J Radiat Oncol Biol Phys 1992;22:1099-1104.
75.
Li G, Mitsumori M, Ogura M, et al.: Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. Int J Clin Oncol 2004;9:179-183.
76.
Kouloulias VE, Dardoufas CE, Kouvaris JR, et al.: Liposomal doxorubicin in conjunction with re-irradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. Clin Cancer Res 2002;8:374-382.
© 2015 S. Karger GmbH, Freiburg
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.